Emerald Advisers, LLC Novo Cure LTD Transaction History
Emerald Advisers, LLC
- $2.35 Billion
- Q4 2024
A detailed history of Emerald Advisers, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Emerald Advisers, LLC holds 547,557 shares of NVCR stock, worth $11.7 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
547,557Holding current value
$11.7 Million% of portfolio
0.69%Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
271Shares Held
73.8MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$259 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$252 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$169 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$92.1 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$60 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.24B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...